Skip to content

Insider · CIK 0001500241

Peacock Jonathan M

Reports to the SEC for 5 companies · THOUSAND OAKS, CA

Transactions

50

Companies

5

Filings

16

CIK

0001500241

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2025-05-08AVTRAvantor, Inc.A Award—
2025-04-28AVTRAvantor, Inc.P Purchase+$104K
2024-05-09AVTRAvantor, Inc.A Award—
2023-05-11AVTRAvantor, Inc.A Award—
2022-05-12AVTRAvantor, Inc.A Award—
2022-04-01AVTRAvantor, Inc.A Award—
2021-03-31Bellerophon Therapeutics, Inc.A Award—
2021-02-25AVTRAvantor, Inc.A Award—
2020-02-21AVTRAvantor, Inc.A Award—
2020-01-23Bellerophon Therapeutics, Inc.A Award—
2019-05-21Bellerophon Therapeutics, Inc.P Purchase+$12.2K
2019-05-21AVTRAvantor, Inc.A Award—
2019-05-21AVTRAvantor, Inc.M Exercise/Conversion—
2019-05-21AVTRAvantor, Inc. · Existing Junior Convertible PreferredM Exercise/Conversion—
2019-01-25Bellerophon Therapeutics, Inc.P Purchase+$500K
2019-01-23Bellerophon Therapeutics, Inc.A Award—
2018-04-02Bellerophon Therapeutics, Inc.A Award—
2017-10-03Kite Pharma, Inc.U Disposition from Tender−$12.2M
2017-10-03Kite Pharma, Inc.D Disposition to Issuer—
2017-10-03Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer−$8.93M
2017-10-03Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer−$1.21M
2017-10-03Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer−$904K
2017-10-03Kite Pharma, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer−$782K
2017-09-29Bellerophon Therapeutics, Inc.P Purchase—
2017-09-29Bellerophon Therapeutics, Inc.Common Stock Warrants (right to buy)P Purchase—
2017-09-22Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2017-09-13Kite Pharma, Inc.G Gift—
2017-06-28Bellerophon Therapeutics, Inc.A Award—
2017-06-20Kite Pharma, Inc.A Award—
2017-06-20Kite Pharma, Inc.Director Stock Option (Right to Buy)A Award—
2016-12-07Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2016-11-29Bellerophon Therapeutics, Inc.P Purchase—
2016-11-29Bellerophon Therapeutics, Inc.Common Stock Warrants (right to buy)P Purchase—
2016-06-01Kite Pharma, Inc.A Award—
2016-06-01Kite Pharma, Inc.Director Stock Option (Right to Buy)A Award—
2016-05-17Bellerophon Therapeutics, Inc.P Purchase+$6,841.5
2016-01-25Bellerophon Therapeutics, Inc.A Award—
2015-12-16Bellerophon Therapeutics, Inc.P Purchase+$35.3K
2015-12-15Bellerophon Therapeutics, Inc.P Purchase+$20.4K
2015-08-19Bellerophon Therapeutics, Inc.P Purchase+$27.4K
2015-06-09Kite Pharma, Inc.Stock Option (Right to Buy)A Award—
2015-05-20Bellerophon Therapeutics, Inc.P Purchase+$48.3K
2015-03-12Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2015-03-12Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award—
2015-02-19Bellerophon Therapeutics, Inc.P Purchase+$250K
2013-10-28AMGNAMGEN INCF Tax Payment−$1.52M
2013-04-25AMGNAMGEN INCF Tax Payment−$286K
2013-01-28AMGNAMGEN INCA Award—
2012-10-28AMGNAMGEN INCF Tax Payment−$1.02M
2012-04-27AMGNAMGEN INCA Award—

Recent filings

16